Non-linear association of admission platelet-to-lymphocyte ratio with 28- and 90-day mortality in critically ill patients with rheumatoid arthritis: a retrospective cohort study
摘要
Critically ill patients with rheumatoid arthritis (RA) have high short-term mortality. The platelet-to-lymphocyte ratio (PLR) reflects RA inflammatory activity. We evaluated whether admission PLR is associated with 28- and 90-day mortality in critically ill patients with RA.
MethodsRA patients were identified from the MIMIC-IV database. Restricted cubic spline (RCS) Cox models characterized the PLR–mortality association and defined a log PLR threshold. Patients were stratified into low, middle, and high PLR groups using this threshold with a ± 0.3 margin (δ). Cumulative incidence of death was assessed using the Kaplan–Meier method. Piecewise Cox models were constructed with incremental adjustment. Subgroup analyses tested the consistency of PLR’s effect across different strata.
ResultsAmong 989 patients, 28- and 90-day mortality were 16.4% and 23.5%. RCS analysis showed a U-shaped association, with the lowest risk at log PLR = 4.725 and higher hazards toward both extremes. In piecewise Cox models, each + 1 log PLR was associated with lower mortality in the low PLR segment (28-day hazard ratio (HR) 0.59; 90-day HR 0.61) but higher risk in the high PLR segment (28-day HR 1.72; 90-day HR 1.67). Associations persisted after multivariable adjustment, with consistent subgroup trends.
ConclusionsAdmission PLR is a significant prognostic marker in critically ill RA, demonstrating a U-shaped relationship with 28- and 90-day mortality. Both abnormally low and high PLR values were associated with higher mortality.